TeraWulf WULF Q1 2026 Disappoints EPS 092 Below 018 Views Should You Sell UDR UDR After 112 Drop 20260515 GE Vernova GEV Q1 2026 Earnings Beat Revenue NA EPS 208 RGC Resources RGCO Reports Strong Q1 2026 Revenue NA EPS Beats Robinhood Opens Platform to AI Agents for Trading and Credit Card Purchases Trainline Raises FullYear Outlook for Second Time in Fiscal 2026 AIDriven Layoffs Stock Boost May Be Illusory Data Suggests Global Leaders Monitor Potential TrumpXi Summit for Trade Policy Signals China Emerges as Leading Competitor in Humanoid Robot Race Says Elon Musk US FirstQuarter GDP Growth Revised Down to 16 Reflecting Slowing Economic Momentum Capital Clean Energy Carriers Corp CCEC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market RY Q1 2026 Earnings EPS Beats Estimates Amid Mixed Market Signals Univest Financial UVSP Q1 2026 Earnings Earnings Beat Estimates by 15 as Net Income Rises Plexus Corp Q1 2026 Earnings EPS Beats Estimates by 678 Revenue Data Withheld SOBR Q3 2025 Earnings Net Loss of 144 per Share Amidst Operational Focus LMFA Q1 2026 Earnings WiderthanExpected Loss Drags on Bitcoin Mining Results Ategrity Specialty Insurance ASIC Edges Higher as Stock Holds Above Key Support Eaton Vance Global Dividend Income Fund ETG Holds Steady Near MidRange as Modest Gains Persist Salesforce CRM Edges Higher as Investors Eye Cloud Growth and Key Resistance Allspring Income Opportunities Fund EAD Inches Up as Support Holds Steady LIDRW Warrants Edge Higher AEye Inc Warrant Tests Key Support at 003 LNT Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher HOVR Q1 2026 Earnings EPS Misses Estimates Despite Stock Surge NEWTG Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Lower AGNCP Q1 2026 Earnings Preferred Shares Benefit as EPS Exceeds Estimates by 145 MBIA Q1 2026 Earnings Significant EPS Miss Reflects Operating Challenges European AI Stocks Buck Broader Market Gloom Amid Heightened Geopolitical Risks GYRE Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage Biodexa Pharmaceuticals BDRX Edges Higher as Stock Tests Key Resistance Levels